ArticleJournal of clinical medicine2023

COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study.

Dongxia Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.